Biogen Inc. buy BMO Capital Markets
Start price
09.11.23
/
50%
€211.40
Target price
09.11.24
€276.44
Performance (%)
-1.37%
Price
24.07.24
€208.50
Summary
This prediction is currently active. With a performance of -1.37%, the BUY prediction for Biogen Inc. by BMO_Capital_Markets is down slightly. This prediction currently runs until 09.11.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -0.144% | -0.144% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $314.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat